What it is
A GLP-1 receptor agonist that models a gut-hormone pathway involved in stomach emptying, appetite signaling, and glucose-dependent insulin release.
Semaglutide2 MGMetabolic collection
2 MG per vial · Box of 10
A GLP-1 receptor agonist that models a gut-hormone pathway involved in stomach emptying, appetite signaling, and glucose-dependent insulin release.
Secure checkout is available through PeptidePay and NOWPayments.
Product guide
A GLP-1 receptor agonist that models a gut-hormone pathway involved in stomach emptying, appetite signaling, and glucose-dependent insulin release.
In the STEP 1 trial, the 2.4 mg treatment group had an average 14.9% weight reduction at 68 weeks, compared with 2.4% in the placebo group.
Research-use noticeThis catalogue summary is educational, not medical advice or a recommendation for use. For qualified laboratory research only—not for human, clinical, veterinary, or household use.